C71T
CANCELLED SECTION 71
06/03/2026
Voltar para busca
Dado oficial do USPTO
OBSEVA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
OBSEVA
ST13
US500000079131578Classe
5, 35, 42, 45
Pedido
79131578
Registro
4557897
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
55
Atualização mais recente
31/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 35, 42, 45
Data de depósito
30/04/2013
Data de registro
01/07/2014
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
06/03/2026
Última transação
31/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Plan-les-Ouates, Genève, CH
Examinador
LEE, YATSYE ISADORA
Unidade examinadora
L70
Titulares e representantes
Titulares
ObsEva SA
E. L. (pessoa física)
Representantes
Karen L. Elbing Clark+Elbing LLP
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medical* and * pharmaceuticalveterinary preparations for the prevention and treatment of reproductive and neuro-psychiatric diseases and disorders; sanitary preparations for the prevention and treatment of reproductive and neuro-psychiatric diseases and disorders; pharmaceutical and biotechnological preparations for the prevention and treatment of reproductive and neuro-psychiatric diseases and disordersfor diagnosistreatment and prevention of medical conditions in humans and animals ; none of these products being for ophthalmic use
Classe 35
Advertising; business management; business administration; office functions; promotion and retail store services featuring pharmaceutical and biotechnological products for diagnosistreatment and prevention of medical conditions in humans and animals; assistance to customers in the marketing of new products; wholesale store services featuring pharmaceutical and biotechnological products for diagnosistreatment and prevention of medical conditions in humans and animals; none of these services being performed in relation to ophthalmic use
Classe 42
Scientific and technological servicesin the field of reproductive and neuro-psychiatry medicine and research and design relating thereto; industrial analysis and research services in the field of reproductive and neuro-psychiatry medicine; researchdevelopmentscientific consultingproviding scientific informationscientific research assistancescientific analysesconducting clinical trials all related to the design and development of pharmaceutical and biotechnological products for diagnosistreatment and prevention of medical conditions in humans and animals ; none of these services being performed in relation to ophthalmic use
Classe 45
Licensing of intellectual property in the field of medicalpharmaceuticalveterinary and sanitary productspharmaceutical and biotechnological products for diagnosistreatment and prevention of medical conditions in humans and animals; legal consulting and regulatory compliance consulting relating to regulatory records and legal authorizations for marketing of pharmaceutical and biotechnological products for diagnosistreatment and prevention of medical conditions in humans and animals before authorities and public administrationsparticularly for medication approval; none of these services being performed in relation to ophthalmic use
Publicações
Histórico de despachos e eventos da marca no USPTO.
55 publicações encontradas
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
01/07/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
18/05/2023
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
23/02/2023
RHRD
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
26/12/2022
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
10/05/2021
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06/04/2021
INPC
INVALIDATION PROCESSED
06/04/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
31/03/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
31/07/2020
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
31/07/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
31/07/2020
ES71
TEAS SECTION 71 RECEIVED
30/06/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/06/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/06/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/06/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/06/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/06/2020
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
18/11/2019
RHRD
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
04/10/2019
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/07/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/03/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
28/11/2014
FICS
FINAL DISPOSITION NOTICE SENT TO IB
24/10/2014
FIMP
FINAL DISPOSITION PROCESSED
24/10/2014
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/10/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
01/07/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/04/2014
PUBO
PUBLISHED FOR OPPOSITION
15/04/2014
GPNX
NOTIFICATION PROCESSED BY IB
10/04/2014
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
26/03/2014
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
26/03/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/03/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/03/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/03/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/03/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/03/2014
ALIE
ASSIGNED TO LIE
03/03/2014
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/02/2014
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/02/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/02/2014
ATRV
ATTORNEY REVIEW COMPLETED
27/01/2014
LIMS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
27/01/2014
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/01/2014
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
08/12/2013
CHLD
CHANGE OF OWNER RECEIVED FROM IB
25/10/2013
RFNT
REFUSAL PROCESSED BY IB
23/09/2013
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
23/08/2013
RFRR
REFUSAL PROCESSED BY MPU
23/08/2013
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
23/08/2013
CNRT
NON-FINAL ACTION WRITTEN
22/08/2013
DOCK
ASSIGNED TO EXAMINER
19/08/2013
MAFR
APPLICATION FILING RECEIPT MAILED
03/07/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/06/2013
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
27/06/2013
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace OBSEVA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.